Comments Requested for Baseline Frailty Parameters for Clinical Trial Populations

The European Medicines Agency has released a document that “outlines the general principles that may be applied for the baseline categorization of older patients enrolled in a clinical trial or other clinical investigation (e.g. registry) on the basis of their frailty status.”  The EMA is seeking comments on this document. You can read it here. Completed comments may be sent here.  The deadline for comments is May 31, 2016.